Biosynex SA (EPA:ALBIO)
France · Delayed Price · Currency is EUR 0.6700
-0.0160 (-2.33%)
Oct 3, 2025, 5:29 PM CET
Biosynex Market Cap
Biosynex has a market cap or net worth of €12.86 million as of October 3, 2025. Its market cap has decreased by -71.88% in one year.
Market Cap
12.86M
Enterprise Value
65.72M
Revenue
101.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.67
Market Cap Chart
Since March 25, 2011, Biosynex's market cap has increased from 8.12M to 12.86M, an increase of 58.34%. That is a compound annual growth rate of 3.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 12.86M | -30.51% |
| Dec 31, 2024 | 18.51M | -78.44% |
| Dec 29, 2023 | 85.85M | -39.13% |
| Dec 30, 2022 | 141.04M | -51.35% |
| Dec 31, 2021 | 289.89M | 91.16% |
| Dec 31, 2020 | 151.65M | 538.46% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 126.77B |
| Sanofi | 95.25B |
| Sartorius Stedim Biotech | 16.74B |
| bioMérieux | 13.44B |
| Eurofins Scientific SE | 10.96B |
| Ipsen | 9.35B |
| ABIVAX Société Anonyme | 5.36B |
| Virbac | 2.63B |